Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Pelthos Therapeutics Inc., 2 years.
Pelthos Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −534 | $26.03 | $13,900 |
| Jul 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −24 | $27.33 | $656 |
| Jun 15, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −224 | $27.12 | $6,075 |
| Jun 15, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −59 | $27.94 | $1,648 |
| May 14, 2026 | Pelthos Therapeutics Inc. | Shares withheld for tax | −144 | $27.01 | $3,889 |
| Apr 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −293 | $20.51 | $6,009 |
| Apr 2, 2026 | Pelthos Therapeutics Inc. | Open-market sale | −265 | $21.36 | $5,660 |
| Nov 25, 2025 | Pelthos Therapeutics Inc. | Open-market sale | −5,999 | $28.00 | $167,972 |
| Nov 25, 2025 | Pelthos Therapeutics Inc. | Open-market sale | −2,000 | $28.14 | $56,280 |
| Nov 25, 2025 | Pelthos Therapeutics Inc. | Open-market sale | −1 | $28.50 | $29 |
| Nov 25, 2025 | Pelthos Therapeutics Inc. | Open-market sale | −2,000 | $28.01 | $56,020 |
| Jul 1, 2025 | Pelthos Therapeutics Inc. | Derivative conversion | +40,000 | $10.00 | $400,000 |
| Jul 1, 2025 | Pelthos Therapeutics Inc. | Derivative conversion | +40,000 | $10.00 | $400,000 |
| Feb 21, 2024 | Pelthos Therapeutics Inc. | Option exercise | +13,649 | $4.80 | $65,515 |
| Feb 21, 2024 | Pelthos Therapeutics Inc. | Option exercise | +6,992 | $4.80 | $33,562 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.